Jacob van Naarden - 01 Feb 2026 Form 4 Insider Report for ELI LILLY & Co (LLY)

Reporting relationship: EVP,Pres LLY Oncology&HdCorpBD
Issuer ticker: LLY
Reported as of: 01 Feb 2026
Net transaction value: -$1,980,308
SEC form: 4
Accepted by SEC: 03 Feb 2026, 16:31:00 UTC
Prior SEC filing: 13 Aug 2025
Next SEC filing: 11 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file

Key filing fact

Jacob van Naarden filed Form 4 for ELI LILLY & Co (LLY) on 03 Feb 2026.

Key facts

This page summarizes Jacob van Naarden's Form 4 filing for ELI LILLY & Co (LLY).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Feb 2026, 16:31.

Change

Previous filing in this sequence was filed on 13 Aug 2025.
Current net transaction value: -$1,980,308.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001661254 Primary reporting owner

Van Naarden Jacob

Relationship: EVP,Pres LLY Oncology&HdCorpBD
Address: LILLY CORPORATE CENTER, INDIANAPOLIS
Signature: /s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file
Signature date: 03 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LLY transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +4,108
Change %: +20%
Price: $0.000000
Shares after: 24,670
Date: 01 Feb 2026
Ownership: Direct

LLY transaction

Common Stock

Tax liability

Transaction value: $1,980,308
Shares: -1,909
Change %: -7.7%
Price: $1037.15
Shares after: 22,761
Date: 01 Feb 2026
Ownership: Direct

LLY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,342
Date: 01 Feb 2026
Ownership: Van Naarden Family Trust
Footnotes: F1

LLY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,302
Date: 01 Feb 2026
Ownership: By spouse
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LLY transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value: $0
Shares: -4,108
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 01 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,108
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.